You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
Losartan Blocks Osteosarcoma-Elicited Monocyte Recruitment, and Combined With the Kinase Inhibitor Toceranib, Exerts Significant Clinical Benefit in Canine Metastatic OsteosarcomaCombination Losartan Plus Toceranib Therapy for Canine OS
|
---|---|
Published in |
Clinical Cancer Research, September 2021
|
DOI | 10.1158/1078-0432.ccr-21-2105 |
Pubmed ID | |
Authors |
Daniel P. Regan, Lyndah Chow, Sunetra Das, Laurel Haines, Eric Palmer, Jade N. Kurihara, Jonathan W. Coy, Alissa Mathias, Douglas H. Thamm, Daniel L. Gustafson, Steven W. Dow |
X Demographics
The data shown below were collected from the profiles of 20 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 5 | 25% |
Canada | 2 | 10% |
United Kingdom | 1 | 5% |
Unknown | 12 | 60% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 17 | 85% |
Scientists | 2 | 10% |
Science communicators (journalists, bloggers, editors) | 1 | 5% |
Mendeley readers
The data shown below were compiled from readership statistics for 50 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 50 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Other | 7 | 14% |
Student > Ph. D. Student | 5 | 10% |
Researcher | 5 | 10% |
Student > Postgraduate | 4 | 8% |
Student > Master | 3 | 6% |
Other | 6 | 12% |
Unknown | 20 | 40% |
Readers by discipline | Count | As % |
---|---|---|
Veterinary Science and Veterinary Medicine | 17 | 34% |
Medicine and Dentistry | 4 | 8% |
Immunology and Microbiology | 4 | 8% |
Linguistics | 1 | 2% |
Computer Science | 1 | 2% |
Other | 2 | 4% |
Unknown | 21 | 42% |
Attention Score in Context
This research output has an Altmetric Attention Score of 352. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 August 2023.
All research outputs
#94,268
of 25,870,940 outputs
Outputs from Clinical Cancer Research
#40
of 13,338 outputs
Outputs of similar age
#2,603
of 438,431 outputs
Outputs of similar age from Clinical Cancer Research
#2
of 109 outputs
Altmetric has tracked 25,870,940 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,338 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.9. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 438,431 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 109 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.